Has Paul Defrino, MD received payments from drug or device companies?

Yes. Drug and device makers reported $253,499 in general payments to Paul Defrino, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Defrino, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Defrino, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Defrino, MD

Orthopaedic Surgery · Palos Heights, ILNPI 1326046319

Payments from drug & device makers

What this record shows

This record is dominated by other: $245,999 of the $253,499 with a category attached, or 97.0%. Arteriocyte Medical Systems, Inc. accounts for 98.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $246,269 and has fallen 98.5% since, to $3,674 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$253,499in general payments, 2019–2025

Across 60 payments — averaging $4224.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arteriocyte Medical Systems, Inc.$250K
Medwest Associates$1K
Medical Device Business Services, Inc.$944
Stryker$703
Johnson & Johnson$389
Paragon 28, Inc.$91
plus $534 from 11 others

$65,050in research payments, 2019–2025

Across 3 payments — averaging $21,683 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Tyber Medical, LLC$65K

What the payments were for

Consulting fees$3,9002%
Food & beverage$2,4001%
Education$1,2000%
Other$245,99997%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arteriocyte Medical Systems, Inc.	4	$249,614
Medwest Associates	2	$1,224
Medical Device Business Services, Inc.	3	$944
Stryker(2 entities)	16	$703
Johnson & Johnson	12	$389
Paragon 28, Inc.	3	$91
Organogenesis Inc.	3	$89
Lightbody Medical Technologies Inc	3	$88
Acumed LLC	2	$75
DJO, LLC	2	$71
Flower Orthopedics Coporation	1	$57
Orthofix Medical, Inc.	3	$35
Kerecis Limited	1	$33
Treace Medical Concepts, Inc.	2	$33
Globus Medical	1	$27
Integra Lifesciences Corporation	1	$16
Fusion Orthopedics USA, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$253,499 in reported general payments places this provider in the 95th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$151,119

Medicare patients

337

Services billed

1,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	48	$722
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	61	$446
Clindamycin Hcl	13	$101
Tramadol Hcl	19	$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Palos Heights

Peter BonuttiEffingham$24.3M
Steven HaddadGlenview$12.6M
Aaron RosenbergChicago$12.4M
Treg BrownHerrin$6.6M
Wayne GoldsteinMorton Grove$4.9M
Steven ChudikWestmont$4.1M
Matthew SquireAurora$2.9M
David ManningBurr Ridge$2.3M
Ritesh ShahMorton Grove$2.3M
Anish KadakiaChicago$2.1M

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →